Loading clinical trials...
Loading clinical trials...
Preventing Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone
Conditions
Interventions
Prednisone
Placebo
Locations
1
South Africa
Site B Khayelitsha HIV/TB clinic
Cape Town, Western Cape, South Africa
Start Date
August 30, 2013
Primary Completion Date
April 1, 2016
Completion Date
April 1, 2017
Last Updated
January 19, 2018
NCT04929028
NCT07071623
NCT01875588
NCT06192160
NCT07199335
NCT03087253
Lead Sponsor
University of Cape Town
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions